Clemmons D R, Camacho-Hubner C, Coronado E, Osborne C K
Department of Medicine, University of North Carolina, Chapel Hill 27599.
Endocrinology. 1990 Dec;127(6):2679-86. doi: 10.1210/endo-127-6-2679.
Breast tumor cell lines have been shown to secrete several distinct polypeptide growth factors, although conflicting results exist for the insulin-like growth factors (IGFs). In contrast a limited number of breast tumor cell lines have definitely been shown to secrete the high affinity IGF binding proteins (IGFBPs) that modify IGF actions. To characterize the types of IGFBPs that are secreted by breast tumor cell lines, conditioned medium was collected from seven separate tumor cell lines, three of which were estrogen receptor (ER) negative, and four of which were ER positive. All three of the ER negative cell lines, MDA-231, MDA-330, and HS578T, secreted binding proteins of 49,000 and 43,000 Mr (IGFBP-3) as well as 29,000 (IGFBP-1) and 24,000 Mr. In contrast, all four ER positive cell lines secreted 34,000 (IGFBP-2) or 24,000 Mr forms, and none secreted the 49,000 and 43,000 or 29,000 Mr forms. BT-20, a cell line that is positive for ER messenger RNA (mRNA) but negative for ER protein, secreted predominantly a 34,000 Mr protein. The amount of total IGFBP activity released in 24 h ranged between 0.4 and 5.6 nM equivalents of IGFBP-1, and there was no significant difference between the ER positive and negative cell lines. The MCF-7 cells that produced predominantly 34,000 and 24,000 Mr forms showed a 1.8-fold increase in IGFBP secretion after estrogen stimulation. Immunoblotting and a specific RIA for IGFBP-1 showed that only the ER negative lines MDA-330, MDA-231, and HS578T secreted this form. Northern blotting analysis for the mRNA encoding this protein showed that both MDA-330 and MDA-231 contained a single 1.6 kilobase mRNA species that hybridized with an IGFBP-1 complementary DNA (cDNA) probe. Immunoblotting analysis of the other cell lines showed that only the 34,000 Mr form secreted by the ER positive cell lines reacted with IGFBP-2 antisera. Exposure of the conditioned media from the three ER negative cell lines to N-glycanase revealed that the 49,000 and 43,000 Mr forms of IGFBP were glycosylated and therefore probably represent IGFBP-3. We conclude that ER negative cell lines secrete three forms of IGFBPs, IGFBP-1, IGFBP-3, and a 24,000 Mr form. In contrast, the ER positive cell lines secrete predominantly IGFBP-2 and the 24,000 Mr form but do not secrete IGFBP-3 or 1.(ABSTRACT TRUNCATED AT 400 WORDS)
已表明乳腺肿瘤细胞系能分泌几种不同的多肽生长因子,不过关于胰岛素样生长因子(IGFs)的研究结果存在矛盾。相比之下,仅有少数乳腺肿瘤细胞系明确被证实能分泌可调节IGF作用的高亲和力IGF结合蛋白(IGFBPs)。为了明确乳腺肿瘤细胞系所分泌的IGFBP类型,从7个不同的肿瘤细胞系收集了条件培养基,其中3个为雌激素受体(ER)阴性,4个为ER阳性。所有3个ER阴性细胞系,即MDA - 231、MDA - 330和HS578T,均分泌分子量为49,000和43,000的结合蛋白(IGFBP - 3)以及分子量为29,000(IGFBP - 1)和24,000的蛋白。相比之下,所有4个ER阳性细胞系均分泌分子量为34,000(IGFBP - 2)或24,000的蛋白形式,且均不分泌分子量为49,000、43,000或29,000的蛋白形式。BT - 20细胞系,其ER信使核糖核酸(mRNA)呈阳性但ER蛋白呈阴性,主要分泌一种分子量为34,000的蛋白。24小时内释放的总IGFBP活性量在0.4至5.6 nM当量的IGFBP - 1之间,ER阳性和阴性细胞系之间无显著差异。主要产生分子量为34,000和24,000蛋白形式的MCF - 7细胞在雌激素刺激后IGFBP分泌增加了1.8倍。针对IGFBP - 1的免疫印迹和特异性放射免疫分析表明,只有ER阴性细胞系MDA - 330、MDA - 231和HS578T分泌这种形式。对编码该蛋白的mRNA进行Northern印迹分析表明,MDA - 330和MDA - 231均含有一个与IGFBP - 1互补脱氧核糖核酸(cDNA)探针杂交的单一1.6千碱基mRNA种类。对其他细胞系的免疫印迹分析表明,只有ER阳性细胞系分泌的分子量为34,000的蛋白形式与IGFBP -